ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BD93YH54
Stock Name / FundiShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerSPMD(USD) LSE
ETF TickerSPMD.LS(USD) CXE
ETF TickerSPMD.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-12-03 (Wednesday)9,097USD 9,402,295LLY holding decreased by -114259USD 9,402,2950USD -114,259 USD 1033.56 USD 1046.12
2025-12-02 (Tuesday)9,097USD 9,516,554LLY holding decreased by -107071USD 9,516,5540USD -107,071 USD 1046.12 USD 1057.89
2025-12-01 (Monday)9,097USD 9,623,625LLY holding decreased by -159926USD 9,623,6250USD -159,926 USD 1057.89 USD 1075.47
2025-11-28 (Friday)9,097USD 9,783,551LLY holding decreased by -262630USD 9,783,5510USD -262,630 USD 1075.47 USD 1104.34
2025-11-27 (Thursday)9,097USD 10,046,181USD 10,046,1810USD 0 USD 1104.34 USD 1104.34
2025-11-26 (Wednesday)9,097LLY holding increased by 228USD 10,046,181LLY holding increased by 202123USD 10,046,181228USD 202,123 USD 1104.34 USD 1109.94
2025-11-25 (Tuesday)8,869LLY holding increased by 48USD 9,844,058LLY holding increased by 404177USD 9,844,05848USD 404,177 USD 1109.94 USD 1070.16
2025-11-24 (Monday)8,821LLY holding increased by 36USD 9,439,881LLY holding increased by 130416USD 9,439,88136USD 130,416 USD 1070.16 USD 1059.7
2025-11-21 (Friday)8,785LLY holding increased by 24USD 9,309,465LLY holding increased by 169201USD 9,309,46524USD 169,201 USD 1059.7 USD 1043.29
2025-11-20 (Thursday)8,761LLY holding increased by 48USD 9,140,264LLY holding decreased by -4901USD 9,140,26448USD -4,901 USD 1043.29 USD 1049.6
2025-11-19 (Wednesday)8,713USD 9,145,165LLY holding increased by 170339USD 9,145,1650USD 170,339 USD 1049.6 USD 1030.05
2025-11-18 (Tuesday)8,713USD 8,974,826LLY holding increased by 72754USD 8,974,8260USD 72,754 USD 1030.05 USD 1021.7
2025-11-17 (Monday)8,713USD 8,902,072LLY holding decreased by -31193USD 8,902,0720USD -31,193 USD 1021.7 USD 1025.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BD93YH54

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-26BUY2281,111.9901,098.100 1,099.489EUR 250,683 820.26
2025-11-26BUY2281,111.9901,098.100 1,099.489EUR 250,683 820.26
2025-11-25BUY481,111.1101,073.250 1,077.036EUR 51,698 818.79
2025-11-24BUY361,075.7201,049.380 1,052.014EUR 37,873 817.52
2025-11-21BUY241,066.6501,038.000 1,040.865EUR 24,981 816.28
2025-11-20BUY481,057.0001,038.250 1,040.125EUR 49,926 815.12
2025-11-11BUY168999.920965.285 968.748EUR 162,750 807.41
2025-11-10SELL-168981.990938.830 943.146EUR -158,449 806.55 Loss of -22,947 on sale
2025-11-07SELL-144 924.370* 805.92 Profit of 116,053 on sale
2025-11-06BUY144949.890916.263 919.626EUR 132,426 805.21
2025-11-04SELL-12915.220883.640 886.798EUR -10,642 804.00 Loss of -994 on sale
2025-10-27BUY48826.410826.420 826.419EUR 39,668 802.64
2025-10-22SELL-24812.430815.940 815.589EUR -19,574 802.35 Loss of -318 on sale
2025-10-20BUY72808.960809.410 809.365EUR 58,274 802.32
2025-10-15SELL-48826.570830.190 829.828EUR -39,832 802.08 Loss of -1,332 on sale
2025-10-14BUY24812.350822.090 821.116EUR 19,707 802.02
2025-10-03BUY24839.870848.130 847.304EUR 20,335 801.79
2025-09-30BUY12763.000766.350 766.015EUR 9,192 801.77
2025-09-25BUY12714.590740.000 737.459EUR 8,850 803.26
2025-07-16SELL-795789.800796.040 795.416EUR -632,356 808.33 Profit of 10,270 on sale
2025-07-14SELL-106799.340800.880 800.726EUR -84,877 808.64 Profit of 839 on sale
2025-07-11SELL-159793.010795.730 795.458EUR -126,478 808.74 Profit of 2,112 on sale
2025-07-10SELL-53790.650799.490 798.606EUR -42,326 808.87 Profit of 544 on sale
2025-07-09SELL-106786.920794.000 793.292EUR -84,089 809.01 Profit of 1,667 on sale
2025-07-03SELL-795780.670783.550 783.262EUR -622,693 809.21 Profit of 20,628 on sale
2025-07-02SELL-106779.280779.840 779.784EUR -82,657 809.42 Profit of 3,141 on sale
2025-06-30BUY153779.530785.000 784.453EUR 120,021 809.62
2025-06-27SELL-106775.450802.500 799.795EUR -84,778 809.86 Profit of 1,067 on sale
2025-06-23SELL-106770.640793.210 790.953EUR -83,841 810.60 Profit of 2,083 on sale
2025-06-20SELL-53762.730786.000 783.673EUR -41,535 810.95 Profit of 1,446 on sale
2025-06-18SELL-103785.030790.630 790.070EUR -81,377 811.33 Profit of 2,190 on sale
2025-06-16SELL-635807.580825.000 823.258EUR -522,769 811.51 Loss of -7,459 on sale
2025-06-13SELL-2,656819.360825.000 824.436EUR -2,189,702 811.45 Loss of -34,485 on sale
2025-06-12SELL-2,366812.030818.560 817.907EUR -1,935,168 811.45 Loss of -15,283 on sale
2025-06-11SELL-106808.610820.720 819.509EUR -86,868 811.47 Loss of -852 on sale
2025-06-06BUY159769.880772.600 772.328EUR 122,800 812.12
2025-06-05BUY212765.680770.000 769.568EUR 163,148 812.49
2025-05-28SELL-159719.390729.990 728.930EUR -115,900 816.05 Profit of 13,853 on sale
2025-05-27BUY159725.220731.310 730.701EUR 116,181 816.81
2025-05-23SELL-477713.710719.640 719.047EUR -342,985 818.56 Profit of 47,467 on sale
2025-05-22BUY106715.200722.190 721.491EUR 76,478 819.44
2025-05-20BUY477747.010763.500 761.851EUR 363,403 820.89
2025-05-16SELL-265757.390758.870 758.722EUR -201,061 822.04 Profit of 16,779 on sale
2025-05-15BUY212733.290738.680 738.141EUR 156,486 822.83
2025-05-14SELL-1,431715.560759.500 755.106EUR -1,080,557 823.80 Profit of 98,297 on sale
2025-05-13BUY106746.060759.500 758.156EUR 80,365 824.50
2025-05-12BUY261755.570765.330 764.354EUR 199,496 825.14
2025-05-09SELL-212734.570762.010 759.266EUR -160,964 825.97 Profit of 14,142 on sale
2025-05-08BUY159751.450769.980 768.127EUR 122,132 826.67
2025-05-07SELL-265776.720784.340 783.578EUR -207,648 827.14 Profit of 11,545 on sale
2025-04-30SELL-53898.950902.500 902.145EUR -47,814 827.37 Loss of -3,963 on sale
2025-04-28SELL-318877.290882.250 881.754EUR -280,398 826.28 Loss of -17,642 on sale
2025-04-23BUY53829.420846.010 844.351EUR 44,751 825.29
2025-04-15BUY689757.180765.310 764.497EUR 526,738 826.78
2025-04-14BUY106754.350759.560 759.039EUR 80,458 827.59
2025-04-09SELL-312753.710754.830 754.718EUR -235,472 830.80 Profit of 23,737 on sale
2025-04-08BUY323726.240763.500 759.774EUR 245,407 832.03
2025-04-04BUY310738.210768.270 765.264EUR 237,232 834.46
2025-04-02BUY150818.220819.850 819.687EUR 122,953 834.66
2025-04-01SELL-465805.230820.660 819.117EUR -380,889 835.03 Profit of 7,398 on sale
2025-03-31BUY2,440825.910828.010 827.800EUR 2,019,832 835.14
2025-03-28BUY310822.510829.780 829.053EUR 257,006 835.30
2025-03-27BUY605821.670826.770 826.260EUR 499,887 835.47
2025-03-26BUY1,545826.760851.410 848.945EUR 1,311,620 835.59
2025-03-25BUY1,055852.350874.920 872.663EUR 920,659 835.37
2025-03-24SELL-155864.900866.870 866.673EUR -134,334 834.97 Loss of -4,913 on sale
2025-03-21BUY21,853837.570850.430 849.144EUR 18,556,344 834.94
2025-03-19BUY53837.010842.130 841.618EUR 44,606 834.80
2025-03-17SELL-110824.760829.000 828.576EUR -91,143 835.12 Profit of 720 on sale
2025-03-14SELL-55813.480815.210 815.037EUR -44,827 835.44 Profit of 1,122 on sale
2025-03-13SELL-55801.650821.110 819.164EUR -45,054 835.93 Profit of 922 on sale
2025-03-12SELL-110821.860834.650 833.371EUR -91,671 836.14 Profit of 305 on sale
2025-03-07BUY165869.580908.000 904.158EUR 149,186 835.91
2025-02-28BUY165920.630921.220 921.161EUR 151,992 830.12
2025-02-26BUY220915.010922.430 921.688EUR 202,771 827.36
2025-02-21BUY330873.680894.400 892.328EUR 294,468 824.18
2025-02-18BUY110857.200862.730 862.177EUR 94,839 821.78
2025-02-11BUY275865.000874.190 873.271EUR 240,150 817.75
2025-02-07BUY110878.310889.360 888.255EUR 97,708 815.27
2025-02-06BUY55870.370887.740 886.003EUR 48,730 814.02
2025-02-05BUY165842.180846.900 846.428EUR 139,661 813.36
2025-02-04BUY55826.070829.040 828.743EUR 45,581 813.06
2025-01-31SELL-110811.080827.350 825.723EUR -90,830 813.17 Loss of -1,380 on sale
2025-01-29SELL-110804.080809.120 808.616EUR -88,948 813.15 Profit of 499 on sale
2025-01-02SELL-324778.070787.000 786.107EUR -254,699 816.86 Profit of 9,964 on sale
2024-12-10SELL-55799.580814.000 812.558EUR -44,691 817.40 Profit of 266 on sale
2024-12-09SELL-55803.580823.700 821.688EUR -45,193 817.85 Loss of -211 on sale
2024-11-27SELL-108788.190794.830 794.166EUR -85,770 821.14 Profit of 2,913 on sale
2024-11-21SELL-220749.920753.000 752.692EUR -165,592 833.89 Profit of 17,864 on sale
2024-11-20SELL-110753.410757.370 756.974EUR -83,267 838.37 Profit of 8,953 on sale
2024-11-18SELL-110727.200734.000 733.320EUR -80,665 852.10 Profit of 13,066 on sale
2024-11-12SELL-330818.860833.990 832.477EUR -274,717 854.32 Profit of 7,208 on sale
2024-11-08SELL-864831.540847.270 845.697EUR -730,682 855.95 Profit of 8,856 on sale
2024-11-07SELL-385797.450802.550 802.040EUR -308,785 860.45 Profit of 22,486 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy